Figures & data
Figure 1. A) Schematic overview of the experimental set-up to monitor phagocytosis of opsonized platelets: CD14+ monocytes were cultured for 9 days with GM-CSF to differentiate into monocyte-derived macrophages (MQ M1). Hereafter, the macrophages were pre-incubated with and without FcγR-blockers. Freshly isolated platelets from HLA-A2+ donors were labeled with PKH26 and pre-incubated with unmodified and glycoengineered anti-HLA monoclonal antibodies in the presence of complement sufficient or heat-inactivated (HI) serum, for antibody and complement opsonization. The macrophages and platelets were washed and co-incubated for 30 minutes at 37°C and analyzed by flow cytometry and Imagestream B) Expression levels of complement receptor 3 (Cd11b/cd18) and FcγR’s (FcγRI, FcγRII, FcγRIII) on the surface of the monocyte-derived macrophages as analyzed by flow cytometry. C-E) Internalization of platelets was determined employing C) conventional and D-E) imaging flow cytometry. Anti-CD42a-BV421 staining, in combination with PKH26, was used to identify platelets attached to the exterior of the cell. Representative images are shown for indicated quadrants obtained by imaging flow cytometry.
![Figure 1. A) Schematic overview of the experimental set-up to monitor phagocytosis of opsonized platelets: CD14+ monocytes were cultured for 9 days with GM-CSF to differentiate into monocyte-derived macrophages (MQ M1). Hereafter, the macrophages were pre-incubated with and without FcγR-blockers. Freshly isolated platelets from HLA-A2+ donors were labeled with PKH26 and pre-incubated with unmodified and glycoengineered anti-HLA monoclonal antibodies in the presence of complement sufficient or heat-inactivated (HI) serum, for antibody and complement opsonization. The macrophages and platelets were washed and co-incubated for 30 minutes at 37°C and analyzed by flow cytometry and Imagestream B) Expression levels of complement receptor 3 (Cd11b/cd18) and FcγR’s (FcγRI, FcγRII, FcγRIII) on the surface of the monocyte-derived macrophages as analyzed by flow cytometry. C-E) Internalization of platelets was determined employing C) conventional and D-E) imaging flow cytometry. Anti-CD42a-BV421 staining, in combination with PKH26, was used to identify platelets attached to the exterior of the cell. Representative images are shown for indicated quadrants obtained by imaging flow cytometry.](/cms/asset/f7e73be8-3660-4d10-8b87-5fe2979d71ad/iplt_a_2129604_f0001_oc.jpg)
Figure 2. Phagocytosis of complement and antibody opsonized platelets by monocyte-derived macrophages A) Absolute and B) relative levels of phagocytosis of platelets incubated with various concentrations of unmodified hIgg1 anti-HLA monoclonal antibodies (mAb) SN230G6+SN607D8 in the presence of complement sufficient serum C) Differences in phagocytosis between platelets pre-incubated with unmodified and glycoengineered hIgg1 SN230G6+SN607D8 mAbs in the presence of complement sufficient serum. D) Absolute and E) relative levels of phagocytosis of platelets pre-incubated with various concentrations of unmodified pan-anti-HLA Class I hIgg1 mAb W6/32 in the presence of complement sufficient serum F) Differences in phagocytosis between platelets pre-incubated with unmodified and glycoengineered hIgg1 W6/32 mAb in the presence of complement sufficient serum. G-H) Relative phagocytosis levels of platelets pre-incubated with 1 µg/ml unmodified or PG LA LA Fc mutant anti-HLA mAbs (SN230G6+SN607D8 or W6/32) in the presence of complement sufficient or heat-inactivated (HI) Serum A-H) the level of phagocytosis (%) was defined as the percentage of the PKH26+ macrophage fraction (Q1+Q2). The data represents the mean and SD of 2 technical replicates of 2–5 different monocyte donors used in 2–4 independent experiments, for each independent experiment also a different platelet donor was used. The color of the data points indicates the different monocyte donors. For normalization, the level of phagocytosis of platelets incubated with 1 µg/ml unmodified anti-HLA mAbs was set at 1, as indicated. An ordinary one-way ANOVA with Dunnet’s multicomparison test was performed for the statistical analysis. *p ≤ .05, ****p ≤ .0001 and ns = non-significant .
![Figure 2. Phagocytosis of complement and antibody opsonized platelets by monocyte-derived macrophages A) Absolute and B) relative levels of phagocytosis of platelets incubated with various concentrations of unmodified hIgg1 anti-HLA monoclonal antibodies (mAb) SN230G6+SN607D8 in the presence of complement sufficient serum C) Differences in phagocytosis between platelets pre-incubated with unmodified and glycoengineered hIgg1 SN230G6+SN607D8 mAbs in the presence of complement sufficient serum. D) Absolute and E) relative levels of phagocytosis of platelets pre-incubated with various concentrations of unmodified pan-anti-HLA Class I hIgg1 mAb W6/32 in the presence of complement sufficient serum F) Differences in phagocytosis between platelets pre-incubated with unmodified and glycoengineered hIgg1 W6/32 mAb in the presence of complement sufficient serum. G-H) Relative phagocytosis levels of platelets pre-incubated with 1 µg/ml unmodified or PG LA LA Fc mutant anti-HLA mAbs (SN230G6+SN607D8 or W6/32) in the presence of complement sufficient or heat-inactivated (HI) Serum A-H) the level of phagocytosis (%) was defined as the percentage of the PKH26+ macrophage fraction (Q1+Q2). The data represents the mean and SD of 2 technical replicates of 2–5 different monocyte donors used in 2–4 independent experiments, for each independent experiment also a different platelet donor was used. The color of the data points indicates the different monocyte donors. For normalization, the level of phagocytosis of platelets incubated with 1 µg/ml unmodified anti-HLA mAbs was set at 1, as indicated. An ordinary one-way ANOVA with Dunnet’s multicomparison test was performed for the statistical analysis. *p ≤ .05, ****p ≤ .0001 and ns = non-significant .](/cms/asset/e3893220-bc64-4e3a-803f-77ce4096c9d2/iplt_a_2129604_f0002_oc.jpg)